ApprovalTrail

Drug · DIN 02536498

PRO-AMOXI CLAV

Yes: authorized and sold in Canada

Authorized, and the company reports that it sells it in Canada.

Status Marketed since July 10, 2023; first marketed July 10, 2023.
Drug Identification Number (DIN)
02536498
Company (DIN owner)
Pro Doc LimiteeLaval, Quebec, Canada
Schedule
Prescription
Dosage form
Tablet
Route
Oral
Therapeutic class (ATC)
Amoxicillin and beta-lactamase inhibitor J01CR02
Class
Human
Record last updated
July 7, 2025

Active ingredients

As listed in the Drug Product Database.

IngredientStrengthPer
AMOXICILLIN (AMOXICILLIN TRIHYDRATE)500 MG
CLAVULANIC ACID (CLAVULANATE POTASSIUM)125 MG

Notices of Compliance

Health Canada approvals that name this DIN.

  • March 22, 2023: NOC 30371Abbreviated New Drug Submission (ANDS) · Administrative: Licensing Agreement Between Two Manufacturers

Other DINs named PRO-AMOXI CLAV